Comparison of Cryotop and micro volume air cooling methods for cryopreservation of bovine matured oocytes and blastocysts.

This study was designed to compare the efficiency of the Cryotop method and that of two methods that employ a micro volume air cooling (MVAC) device by analyzing the survival and development of bovine oocytes and blastocysts vitrified using each method. In experiment I, in vitro-matured (IVM) oocytes were vitrified using an MVAC device without direct contact with liquid nitrogen (LN2; MVAC group) or directly plunged into LN2 (MVAC in LN2 group). A third group of IVM oocytes was vitrified using a Cryotop device (Cryotop group). After warming, vitrified oocytes were fertilized in vitro. There were no significant differences in cleavage and blastocyst formation rates among the three vitrified groups, with the rates ranging from 53.1% to 56.6% and 20.0% to 25.5%, respectively; however, the rates were significantly lower (P < 0.05) than those of the fresh control group (89.3% and 43.3%, respectively) and the solution control group (87.3% and 42.0%, respectively). In experiment II, in vitro-produced (IVP) expanded blastocysts were vitrified using the MVAC, MVAC in LN2 and Cryotop methods, warmed and cultured for survival analysis and then compared with the solution control group. The rate of development of vitrified-warmed expanded blastocysts to the hatched blastocyst stage after 24 h of culture was lower in the MVAC in LN2 group than in the solution control group; however, after 48-72 h of culture, the rates did not significantly differ between the groups. These results indicate that the MVAC method without direct LN2 contact is as effective as the standard Cryotop method for vitrification of bovine IVM oocytes and IVP expanded blastocysts.

Vitrification was initially used for cryopreservation of mouse embryos [1], and it has become a viable alternative to traditional freezing protocols, as it prevents chilling injury and ice crystal formation. During the vitrification procedure, cells and tissues are exposed to a high concentration of cryoprotectants (CPAs), which effectively dehydrate the cells prior to initiation of the cooling process. Extended exposure to a high concentrations of permeating CPAs is detrimental to cells [2]. To achieve a high probability of successful vitrification, the volume of the vitrification solution is minimized, which increases the cooling velocity and heat transfer and prevents ice crystal formation [3]. A rapid cooling rate during vitrification is the key to successful vitrification that avoids chilling injury in sensitive cells [4].

Oocytes are highly sensitive to chilling because of their low surface-to-volume ratio, which makes it difficult for water and CPAs to move across the cell plasma membranes [5]. Furthermore, vitrification of mature oocytes that are in metaphase of meiosis II (MII) leads to disorganization or disruption of the meiotic spindle, resulting in chromosome aberration [6, 7]. The first successful vitrification of MII bovine oocytes was performed using electron microscope grids and a 0.25-ml straw as a vitrification device [8]. Since then, other methods, such as the solid surface vitrification and Cryotop methods, have been found to allow for high-efficiency vitrification of MII bovine oocytes [9, 10]. In contrast, embryos are more cryotolerant than oocytes because the properties of the plasma membrane change after fertilization, promoting dehydration and reducing ice formation during cryopreservation [11]. Massip et al. [12] were the first to report successful vitrification of bovine embryos using a 0.25-ml straw. Since then, several vitrification devices have been developed, each with a specific method of minimizing the volume of the vitrification solution: the Cryoloop [13], nylon loop [14], hemi-straw system [15], electron microscopy grid [8], open pulled straw [16], glass capillary [17] and Cryotop [18].

The Cryotop method is one of the most efficient techniques for vitrification of both oocytes and embryos, resulting in high survival and developmental rates in pigs [19,20,21], cattle [8, 9, 22], buffalo [23,24,25] and humans [26, 27]. However, because it is an open method in which samples come into direct contact with LN2, it allows for the possibility of microbial disease transmission and viral contamination [28]. Therefore, a new device and the corresponding micro volume air cooling (MVAC) method have been invented to prevent direct contact with LN2 during vitrification. The MVAC and Cryotop devices are equally effective for vitrification of in vivo-derived porcine expanded blastocysts [29]. However, there have been no reports on application of the MVAC device (both with and without direct exposure to LN2) to oocytes and embryos at the blastocyst stage in bovine species.

The objective of this study was to compare the efficacy of the MVAC and Cryotop devices for vitrification of both bovine in vitro-matured (IVM) oocytes and bovine in vitro-produced (IVP) embryos at the blastocyst stage by analysis of subsequent in vitro development after warming.

Materials and Methods

Chemicals and media

All reagents were purchased from Sigma-Aldrich Corporation (St. Louis, MO, USA), unless otherwise indicated.

Oocyte collection and IVM

Collection and IVM of bovine follicular oocytes were performed as previously described [30]. Briefly, slaughterhouse ovaries were washed and stored in physiological saline supplemented with 50 µg/ml gentamicin for approximately 20 h at 20 C. Cumulus-oocyte complexes (COCs) were aspirated from follicles (2–8 mm in diameter) using a 5 ml syringe connected to a 19-gauge needle. The IVM medium consisted of 25 mM Hepes-buffered TCM199 (Life Technologies Gibco-BRL Division, Grand Island, NY, USA) and 5% calf serum (CS; Life Technologies Gibco-BRL Division). COCs were washed twice with IVM medium and then cultured for 20 h in 600-µl droplets of IVM medium (80–100 oocytes/droplet) that were covered with paraffin oil (Nacalai Tesque, Kyoto, Japan) in 35-mm plastic dishes (Nalge Nunc International, Roskilde, Denmark) at 38.5 C under a humidified atmosphere of 5% CO2 in air.

Vitrification and warming of oocytes

Twenty hours after IVM, cumulus cells were partially removed by repeated pipetting using a fine glass pipette in Dulbecco’s phosphate-buffered saline (DPBS; Life Technologies Gibco-BRL Division) supplemented with 0.1% (w/v) hyaluronidase. IVM oocytes with two to three layers of cumulus cells on their surface were subsequently washed five times in holding medium (HM), which consisted of 25 mM Hepes-buffered TCM 199 supplemented with 20% (v/v) CS. Thereafter, they were vitrified using either the MVAC device or the Cryotop device (Kitazato BioPharma, Shizuoka, Japan) in a vitrification solution, as described previously by Dinnyes et al. [9]. Briefly, three separate groups of 5–10 oocytes were placed in equilibration medium, which was composed of HM supplemented with 4% (v/v) ethylene glycol (EG; Wako Pure Chemical Industries, Osaka, Japan), for 12–15 min at 38.5 C and then transferred into a vitrification solution composed of HM supplemented with 35% EG, 50 mg/ml polyvinyl pyrrolidone, and 0.4 M trehalose. Then, one group of 5–10 oocytes (Cryotop group) was placed on a Cryotop sheet as described previously [10], while another group was placed in a small volume of vitrification solution (<1 µl) on the inner surface of a stainless steel sheet in the MVAC device, which was then plunged directly into LN2 (MVAC in LN2 group). The third group was treated with the MVAC method (MVAC group), as follows: A 0.25-ml plastic straw was precooled in LN2 while sealed with a plastic plug to prevent LN2 from entering the straw. Thereafter, the plug was removed, and the entire of the MVAC device containing oocytes was then inserted into the straw. The straw containing the MVAC device was then plunged into LN2 [29]. Each cryodevice containing oocytes was kept in LN2 for at least 24 h.

While submerged in LN2, cover straws were removed from the vitrification devices used for the Cryotop and MVAC in LN2 groups, followed by removal of the devices from inner straws. For the MVAC group, the cover straw was removed from the device above the surface of the LN2, ensuring that the oocytes could be warmed without directly contacting LN2. Thereafter, the devices were transferred into 3 ml of warming solution, which was composed of HM supplemented with 0.3 M trehalose, in a 35-mm plastic dish at 38.5 C. Two minutes later, oocytes were consecutively transferred to 500-µl droplets of HM supplemented with 0.15, 0.075 or 0.0375 M trehalose at 38.5 C, where they were held for 1 min each. They were washed three times with HM at 38.5 C and then transferred into IVM medium and incubated for an additional 2 h at 38.5 C in a humidified atmosphere of 5% CO2 in air.

In vitro fertilization (IVF)

The vitrified-warmed oocytes and non-vitrified oocytes were subjected to IVF as described previously [30]. Briefly, frozen semen from a Japanese Black bull was thawed in a 37 C water bath for 30 sec and then centrifuged in 3 ml of 90% Percoll solution at 740 × g for 10 min. The pellet was resuspended and centrifuged in 6 ml of BO medium [31] supplemented with 10 mM hypotaurine (Novo-heparin Injection 1000; Aventis Pharma, Tokyo, Japan) and 4 U/ml heparin (Novo-heparin Injection 1000; Aventis Pharma) at 540 × g for 5 min. Then, the pellet was resuspended with BO medium supplemented with 20 mg/ml BSA (IVF medium) to reach a final concentration of 3 × 106 spermatozoa/ml. To prepare fertilization droplets, 100-µl droplets of the sperm suspension were placed in a 35-mm dish and covered with paraffin oil. A group of 20 oocytes was washed three times in IVF medium. The oocytes were transferred into the fertilization droplets and cultured for 6 h at 38.5 C under a humidified atmosphere of 5% CO2 in air.

In vitro culture (IVC) of embryos

After IVF, cumulus cells and sperm attached to oocytes were removed by gentle pipetting with a fine glass pipette. IVC was performed in CR1aa medium [32] supplemented with 5% CS and covered with paraffin oil in a 35-mm dish at 38.5 C under a humidified atmosphere of 5% CO2 in air. Twenty presumptive zygotes derived from vitrified oocytes and fresh oocytes (Experiment I) were cultured in a 100-µl IVC drop, and 80 presumptive zygotes derived from vitrified oocytes and fresh oocytes (Experiment II) were cultured in a 600-µl IVC drop. After culture for 48 h, cleavage rates were recorded. The blastocysts were continuously cultured in the same drop without changing the medium. Blastocyst formation rates were recorded on days 7, 8, and 9 (day 0 was defined as the day of IVF).

Vitrification of IVP expanded blastocysts

Grade 1 IVP expanded blastocysts (IETS code 7; n = 345) obtained on day 7 were vitrified using either the Cryotop or MVAC device. Briefly, the expanded blastocysts were washed three times in HM consisting of DPBS supplemented with 20% (v/v) CS. The expanded blastocysts were then placed in equilibration medium, which was composed of HM supplemented with 7.5% EG and 7.5% dimethyl sulfoxide (DMSO) for 3 min at 38.5 C, and then transferred into a vitrification solution composed of HM supplemented with 16.5% EG, 16.5% DMSO and 0.5 M sucrose (VS33 solution), where they were held for 1 min. Then, a group of three to five blastocysts was placed either on the inner surface of an MVAC device [29] or on a Cryotop device before vitrification by the MVAC, MVAC in LN2, or Cryotop method. Thereafter, cryodevices containing IVP expanded blastocysts were immediately plunged into LN2, where they were stored for at least 24 h.

Culture of vitrified-warmed IVP expanded blastocysts

In each vitrification method, cover straws were removed from the devices in a process similar to the cover straw removal process used during vitrification and warming of oocytes, which was described above. After being washed in HM three times, the devices were placed in TCM-199 (Life Technologies Gibco-BRL Division) supplemented with 20% CS and 0.1 mM β-mercaptoethanol, and then cultured for 72 h in the same medium (3–4 blastocysts/20 µl) covered with paraffin oil at 38.5 C in a humidified atmosphere of 5% CO2 in air. To evaluate blastocyst survival after vitrification-warming, the percentages of vitrified-warmed expanded blastocysts that developed to the hatched blastocyst stage were determined at 24, 48, and 72 h of IVC.

Evaluation of blastocyst cell numbers with differential staining

Differential staining of inner cell mass (ICM) and trophectoderm (TE) nuclei in blastocysts was performed as previously described [33], with slight modifications. Briefly, the blastocysts were simultaneously treated with 0.1 mg/ml propidium iodide (PI) and 0.2% Triton X-100 dissolved in DPBS for 60 sec to permeabilize the membrane and stain the nuclei of TE cells. The blastocysts were then treated for 5 min with 25 µg/ml Hoechst 33342 (Calbiochem, San Diego, CA, USA) dissolved in 99.5% ethanol, and then mounted on glass slides in glycerol droplets that were flattened by cover slips. The blastocysts were examined under UV light with an excitation wavelength of 330–385 nm using an epifluorescence microscope (IX-71; Olympus, Tokyo, Japan). The nuclei of TE cells labeled with both PI and Hoechst 33342 appeared pink or red, whereas the nuclei of ICM cells labeled only with Hoechst 33342 appeared blue. A digital image of each blastocyst was captured, and the cell numbers of both cell types were counted using the NIH ImageJ (v. 1.40) software [34]. Numbers of ICM and TE cells were counted separately in blastocysts that had clearly distinguishable populations of red and blue nuclei.

Experimental design

Experiment I: This experiment was designed to investigate the effect of cryodevices (MVAC and Cryotop) used for vitrification of bovine IVM oocytes on oocyte development rates after IVF. To serve as the solution control group, some IVM oocytes were exposed to equilibration medium, vitrification medium and warming solutions without cooling. Untreated oocytes served as the fresh control group. In vitrified groups, IVM oocytes were randomly vitrified by the MVAC, MVAC in LN2 or Cryotop method (MVAC, MVAC in LN2 and Cryotop groups, respectively) and then warmed before IVF. After IVF, all oocytes were cultured in vitro. Rates of development of the oocytes to the blastocyst stage and cell numbers of the obtained blastocysts were compared between all five groups.

Experiment II: The objective of this experiment was to compare the efficiencies of the cryodevices for the vitrification of IVP blastocysts. Grade 1 IVP expanded blastocysts (IETS quality code 1, stage code 7; n = 455) were randomly divided into four groups; the expanded blastocysts were 1) exposed to vitrification and warming solutions (solution control group), 2) vitrified by the MVAC method (MVAC group), 3) vitrified by the MVAC in LN2 method (MVAC in LN2 group) or 4) vitrified by the Cryotop method (Cryotop group). Blastocyst survival after vitrification-warming was assessed by their hatching ability during 72 h of additional IVC.

Statistical analysis

The percentages of IVM-IVF oocytes that developed to the blastocyst stage and survival rates of IVP blastocysts after vitrification-warming were arcsine transformed. Cell numbers of the embryos were expressed as untransformed means ± standard error of the mean (SEM). Data were analyzed by analysis of variance (ANOVA). Differences were considered to be significant when P < 0.05.

Results

Experiment I

The developmental rates of fresh and vitrified-warmed oocytes after IVF are shown in Table 1. Oocytes from all vitrification groups showed lower rates of cleavage and development to the blastocyst stage than those from the fresh and solution control groups (P < 0.05). Cleavage rates of the vitrified oocytes did not differ between the MVAC, MVAC in LN2 and Cryotop groups. The cleavage rates of oocytes in all vitrified groups were lower than those of oocytes in the fresh and solution control groups (P < 0.05); however, there was no difference in these rates between the two control groups. Rates of oocyte development to the blastocyst stage did not differ between the MVAC, MVAC in LN2 and Cryotop groups on days 7, 8 or 9; however, they were lower than those of the fresh and solution control groups (P < 0.05).

Table 1.

In vitro development of fresh bovine IVM oocytes (fresh control), bovine IVM oocytes treated with vitrification solution (solution control) and bovine IVM oocytes vitrified using the MVAC or Cryotop device after IVF and in vitro culture for 9 days

Treatment group	No. of IVF oocytes	Oocytes cleaved and developed into blastocysts (%)
		Cleaved (day 2*)		Blastocyst (BL)
		Total	≥ 5 Cells	Day 7	Day 8	Day 9	Total BL
Fresh control	150	134	90	48	14	3	65
		(89.3)a	(60.0)a	(32.0) a	(9.3)a	(2.0)a	(43.3)a
Solution control	150	131	93	43	15	5	63
		(87.3)a	(62.0)a	(28.7)a	(10.0)a	(3.3)a	(42.0)a
MVAC	145	77	59	26	6	1	33
		(53.1)b	(40.7)b	(17.9)b	(4.1)b	(0.7)b	(22.9)b
MVAC in LN2	145	81	60	24	4	1	29
		(55.9)b	(41.4)b	(16.6)b	(2.8)b	(0.7)b	(20.0)b
Cryotop	145	82	63	30	5	2	37
		(56.6)b	(43.5)b	(20.7)b	(3.5)b	(1.4)b	(25.5)b

Five replications were performed. a,b Values within a single column that have different superscripts are significantly different at P < 0.05 using one-way ANOVA. * Day 0 was defined as the day IVF was performed. MVAC: IVM oocytes that were vitrified by inserting the MVAC device containing them into a precooled 0.25-ml plastic straw. MVAC in LN2: IVM oocytes that were vitrified by plunging the MVAC device containing them directly into LN2. Cryotop: IVM oocytes that were vitrified by the Cryotop method.

As shown in Fig. 1, there were no significant differences between all five groups in the total number of nuclei in blastocysts obtained on day 9. Similarly, no significant difference was found in the numbers of ICM and TE cells between all groups.

Fig. 1.

Cell numbers in blastocysts derived from fresh bovine IVM oocytes (fresh control), bovine IVM oocytes treated with vitrification solution (solution control) or bovine IVM oocytes vitrified by the MVAC or Cryotop methods after IVF and in vitro culture for 9 days. Data presented as the mean no. of nuclei ± SEM. Fresh control: IVM oocytes without any vitrification treatments. Solution control: IVM oocytes that were exposed to vitrification and warming solutions. MVAC: IVM oocytes that were vitrified by inserting the MVAC device containing them into a precooled 0.25-ml plastic straw. MVAC in LN2: IVM oocytes that were vitrified by plunging the MVAC device containing them directly into LN2. Cryotop: IVM oocytes that were vitrified by the Cryotop method. ICM: inner cell mass. TE: trophectoderm. No significant differences in ICM and TE cell numbers were detected between the treatment groups at P < 0.05 using one-way ANOVA.

Experiment II

Rates of development to the hatched blastocyst stage of vitrified-warmed expanded blastocysts after 24 h of IVC differed between the MVAC in LN2 and solution control groups (35.1% and 62.4%, respectively; P < 0.05); however, there were no significant differences in these rates between the solution control, MVAC and Cryotop groups. The rates of hatched embryos at 48 and 72 h of culture did not differ between the Cryotop, MVAC and MVAC in LN2 groups; moreover, no difference was observed in the rates of hatched embryos between the vitrified and solution control groups (Table 2).

Table 2.

Development to the hatched blastocyst stage of in vitro-produced expanded blastocysts vitrified using the MVAC or Cryotop device, warmed and cultured in vitro for 72 h

Vitrification method	No. of cryopreserved embryos	No. of hatched embryos (%)
		24 h	48 h	72 h
Solution control	117	73a	94	109
		(62.4%)	(80.3%)	(93.2%)
MVAC	110	53ab	88	102
		(48.2%)	(80.0%)	(92.7%)
MVAC in LN2	114	40b	82	104
		(35.1%)	(71.9%)	(91.2%)
Cryotop	114	61ab	89	102
		(53.5%)	(78.1%)	(89.5%)

Six replications were performed. a, b Values within a single column that have different superscripts are significantly different at P < 0.05 using one-way ANOVA. Solution control: IVP expanded blastocysts that were exposed to vitrification and warming solutions. MVAC: IVP expanded blastocysts that were vitrified by inserting the MVAC device containing them into a precooled 0.25-ml plastic straw. MVAC in LN2: IVP expanded blastocysts that were vitrified by plunging the MVAC device containing them directly into LN2. Cryotop: IVP expanded blastocysts that were vitrified by the Cryotop method. No significant difference in development to the hatched blastocyst stage was detected between the treatment groups at P < 0.05 using one-way ANOVA.

Discussion

In this study, it was demonstrated for the first time that both bovine IVM oocytes and IVP expanded blastocysts can be successfully cryopreserved by the MVAC device. The triangular MVAC sheet (1.0 mm wide, 60 mm long, and 0.2 mm thick) is made from stainless steel, which supports high rates of heat exchange. High survival and developmental rates of vitrified-warmed IVM oocytes (Experiment I) and IVP embryos at the expanded blastocyst stage (Experiment II) were also achieved by the MVAC device as a result of rapid heat exchange and high cooling and warming rates.

Although Cryotop vitrification has been reported to be a highly efficient method for cryopreservation of bovine oocytes [9, 10] and embryos [35], the 0.4-mm-wide and 20-mm-long sheet allows for the placement of oocytes and embryos in less than 1 µl of vitrification solution [36]. Thus, only 5–10 oocytes can be cryopreserved on each Cryotop sheet [37]. In contrast, the longer sheet used in the MVAC method (60 vs. 20 mm) can hold as many as 25 oocytes or blastocysts, according to our preliminary study (unpublished data).

Many viral and bacterial agents can survive in LN2 and be transmitted into cryopreserved and banked embryos [38, 39]. Potential sources of contamination during freezing are the cryopreserved samples and LN2 themselves [40]. For example, when an infected embryo is stored in LN2, cross-contamination between it and LN2 may occur. Also, as water evaporates, it cools and freezes above the LN2 tank, forming small ice crystals with a high electrostatic charge. These ice crystals can capture airborne microorganisms, which in turn, fall into the tank [41, 42]. Pessoa et al. [43] reported that up to 84.3% of farms and 100% of companies in Southern Brazil use LN2 contaminated with bacteria, fungi, or both. Therefore, an alternative method for cryopreservation that avoids exposing samples directly to LN2 is required. In this study, the MVAC method without LN2 contact was shown to be as effective as the MVAC in LN2 and Cryotop methods, in which samples had direct contact with LN2. Because the actual heat transfer in the MVAC device was not investigated in Experiment I (because of the closed carriers), the MVAC device was employed in two separate methods to determine which method provided greater heat exchange during cooling. The results suggest that the heat exchange and cooling rates associated with direct plunging of the device into LN2 (MVAC in LN2) and without direct contact between the device and LN2 (MVAC) did not differ significantly from each other. A previous report on porcine embryos produced in vivo also showed equal efficiency between the MVAC and Cryotop vitrification methods [29]. However, because the stainless steel sheet of the MVAC device is non transparent, loading a small volume of the vitrification solution (<1 µl) requires a great amount of skill.

In this study, a toxicity test of the vitrification solution showed that treatment with CPAs did not affect the developmental competence of vitrified IVM oocytes. Similar results have been reported previously in bovine IVM oocytes [8, 9, 37].

We achieved relatively high rates of development of vitrified-warmed IVM oocytes to the blastocyst stage, ranging from 20% to 25.5% for all vitrification methods. In general, higher cooling rates are expected to be achieved by open system methods, such as the Cryotop and MVAC in LN2 methods, than by closed system methods, such as the MVAC method, because conductive heat transfer is very rapid in LN2 [44]. However, our results showed that vitrified-warmed IVM oocytes had similar levels of competence to development to the blastocyst stage in all vitrification groups (P < 0.05). These results indicate that all of the cooling systems investigated in this study are equally effective for cryopreservation of bovine IVM oocytes. Moreover, for the MVAC device, the recovery rates after warming of both bovine IVM oocytes and IVP expanded blastocysts were nearly 100% and did not significantly differ from those of the standard Cryotop method. The recovery rates for the MVAC device in our study were higher than those measured in a previous study of vitrified mouse oocytes, in which the recovery rates were 62% in an open pulled straw (OPS) and 81% in a 0.25-ml plastic straw [45]. Abdelhafez et al. [28] reported lower recovery rates in mouse embryos vitrified by the Cryotip method than we report here; their recovery rates were 85% for the cleavage stage and 75% for the blastocyst stage. In this study, the cleavage rates of vitrified-warmed bovine IVM oocytes after IVF did not differ significantly between the treatment groups, ranging from 53% to 56%; these rates are higher than the cleavage rates previously reported by Vajta et al. [22] (47–50%) using the OPS method. Similarly, Sripunya et al. [37] reported that the cleavage rate of vitrified-warmed bovine IVM oocytes was 41%. Our findings suggest that bovine IVM oocytes vitrified by the MVAC method, avoiding direct contact between the samples and LN2, can be fertilized with an efficiency equal to that of oocytes vitrified by other standard methods that allow direct contact with LN2 (Cryotop and MVAC in LN2). Furthermore, we found similar blastocyst rates and qualities (as measured by the numbers of TE cells and ICM cells, as well as by the total numbers of nuclei in the blastocysts) between the MVAC, MVAC in LN2 and Cryotop groups.

The results of our comparison study of the effect of cryodevices on the survival of IVP expanded blastocysts after vitrification-warming in experiment II showed that there was no significant difference between the Cryotop, MVAC, MVAC in LN2, and solution control groups (P < 0.05). However, the rate of hatched blastocysts after warming and 24 h of IVC was lower in the MVAC in LN2 group than in the solution control group. The reasons for this low rate of hatched blastocysts in the MVAC in LN2 group are not clear; however, it may be partially explained by the difficulty of controlling the vitrification solution volume (< 1 µl) in the MVAC device. Indeed, a higher volume of vitrification solution, which acts as an insulator surrounding the blastocysts, has been reported to result in decreased cooling viscosity and heat transfer [3, 36]. However, the blastocyst viability in our MVAC in LN2 group was only slightly lower; later, at 48 and 72 h after warming, there were no significant differences in the rates of hatched blastocysts between the groups. Although direct comparison between our results and results obtained by previous studies is impossible, our results showed higher survival rates for vitrified-warmed bovine blastocysts treated with the Cryotop method than those previously reported using the same Cryotop method: 75% [46], 81.9% [47] and 47.6% [48].

In conclusion, the results of this study demonstrate that the Cryotop and MVAC cooling systems are equally effective for vitrification of both bovine IVM oocytes and bovine IVP embryos at the expanded blastocyst stage, resulting in high survival and developmental rates. Thus, we suggest that the MVAC system is a new, useful method for vitrification of both bovine IVM oocytes and bovine IVP embryos. Our results also show that the modified MVAC device used in the MVAC method may address biosafety concerns by serving as a closed carrier system that prevents exposure to LN2. However, it is necessary for future studies to investigate live calf production from oocytes and embryos vitrified by the MVAC method.